NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
INAGENE DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INAGENE DIAGNOSTICS
ST13
US500000088255707Class
35, 41, 42, 44
Filing
88255707
Registration
7470557
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
67
Latest update
08/13/2024
Trademark type
Word
Nice classes
35, 41, 42, 44
Filing date
01/09/2019
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Toronto, CA
Examiner
SABAGH, LAILA
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Inagene Diagnostics Inc.
Representatives
Matthew Warner-Blankenship Dentons Davis Brown
Technical classification
Nice Classes
Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising the goods and services of others focused on the application of personal genetic information for pain managementmental health and other comorbid conditions; developing promotional campaigns focused on the application of personal genetic information for pain managementmental health and other comorbid conditionsmarketing servicesmarketing consultancy for businesses in the field of personal genetic information for pain managementmental health and other comorbid conditionsall the foregoing not including veterinary or plant applications
Class 41
Providing online non-downloadable audio and video recordings containing information in the field of medical testing servicesgenetic testing and genetic screening over a global computer network
Class 42
Genetic testing and genetic screening services for scientific research purposes; scientific research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatmentspharmaceuticals and clinical trials; providing genetic-based nutritional and pharmaceutical research information via the internet and via printed publications; providing clinical laboratory testing servicespharmacogenetic testsgene sequencing-based tests and genotyping based on the assessmentdevelopment and application of human genomic discoveries in the pharmaceuticalinformatics and human clinical diagnostic industriesall the foregoing not including veterinary or plant applications; medical research in the fields of genomics and genetics; providing genetic-based medical research information via the internet and via printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing temporary use of on-line non-downloadable software applications related to medical conditions addressed by medical testing servicesplatform as a service (PAAS) featuring computer software and mobile device applications for accessing information in the field of pain managementmental health and other comorbid conditions; providing genetic testing information for patients and healthcare professionals via an internet website portal; online services relating to medical testing servicesproviding genetic testing and genetic screening information for patients and healthcare professionals via an internet website portal
Class 44
Medical diagnostic testing services and providing medical information in the form of personalized reports online in the field of genetic testing for medical purposes; providing clinical laboratory testing servicespersonalized medical tests based on the assessmentdevelopment and application of human genomic discoveries in the medical industry; online medical testing servicesgenetic testing and genetic screening; Medical information servicesproviding personalized information online in the field of genetic testing for medical purposes; medical information servicesreporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatmentspersonal genetic information for pain managementmental health and other comorbid conditions and for understanding individual responses to medicationall the foregoing not including veterinary or plant applications; medical information servicesanalyzing pharmacogenetic testing service results and relevance to medical and nutritional treatmentsthe interaction between personal genetic information and pharmaceuticalsall the foregoing not including veterinary or plant applications; medical information servicespreparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatmentsanalyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticalsall the foregoing not including veterinary or plant applications
Publications
History of USPTO decisions and trademark events.
67 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/24/2024
NREV
NOTICE OF REVIVAL - E-MAILED
04/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/10/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/10/2024
PGRR
PETITION GRANTED - RESPONSE RECEIVED
04/10/2024
APET
ASSIGNED TO PETITION STAFF
04/08/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/04/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
03/04/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
01/22/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
01/19/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
01/19/2024
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
06/06/2023
GPRA
PRIORITY ACTION E-MAILED
06/06/2023
CPRA
PRIORITY ACTION WRITTEN
06/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2023
ALIE
ASSIGNED TO LIE
02/14/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/06/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
08/06/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
08/06/2022
CNSI
SUSPENSION INQUIRY WRITTEN
08/06/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/24/2022
DOCK
ASSIGNED TO EXAMINER
03/07/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/06/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/06/2021
GNSL
LETTER OF SUSPENSION E-MAILED
12/06/2021
CNSL
SUSPENSION LETTER WRITTEN
12/06/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/03/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/03/2020
GNSL
LETTER OF SUSPENSION E-MAILED
12/03/2020
CNSL
SUSPENSION LETTER WRITTEN
12/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/03/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2020
ALIE
ASSIGNED TO LIE
11/29/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
11/02/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
05/01/2020
GNSI
INQUIRY TO SUSPENSION E-MAILED
05/01/2020
CNSI
SUSPENSION INQUIRY WRITTEN
05/01/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/01/2019
GNSL
LETTER OF SUSPENSION E-MAILED
11/01/2019
CNSL
SUSPENSION LETTER WRITTEN
11/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2019
ALIE
ASSIGNED TO LIE
10/23/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/17/2019
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
09/24/2019
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
09/24/2019
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
09/24/2019
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
09/24/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
08/14/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/14/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
08/14/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/14/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/03/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/02/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/25/2019
GNRT
NON-FINAL ACTION E-MAILED
03/25/2019
CNRT
NON-FINAL ACTION WRITTEN
03/25/2019
DOCK
ASSIGNED TO EXAMINER
03/25/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/30/2019
NWAP
NEW APPLICATION ENTERED
01/12/2019
Continuous trademark protection
Get notified about every new filing that threatens INAGENE DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.